PDF factsheet
      Z

antiplatelets drug in thrombosis prevention for medical patients, clinical trials results

aspirin + dipyridamol versus control
Chicago, 1982
aspirin, 300 mg bid, and dipyridamole, 75 mg tid
versus
control
patients with acute spinal cord injury open
aspirin + dipyridamol versus placebo
Frankfurt, 1981
A+Dip,A1320
versus
placebo
patients with myocardial infarctiondouble-blind
dipyridamol + ASA versus placebo
Denver-Il , 1980
dipyridamole 100 mg a day and aspirin 1200 mg a day
versus
placebo
patients with recurring venous thromboembolism double-blind
Follow-up duration: 18 months
ticlopidine versus placebo
McKenna-II , 1983
Ticlopidine
versus
placebo
high risk (post CVA) medical patients double-blind

  Options


in first

in second

  Filter